EUCALIA Inc
TSE:286A
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
766
1 209
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| JP |
|
EUCALIA Inc
TSE:286A
|
30.2B JPY |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
104.7B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.4B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
74.2B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.2B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.5B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
7.6B USD |
Loading...
|
Market Distribution
| Min | -125 500% |
| 30th Percentile | 4.2% |
| Median | 7% |
| 70th Percentile | 10.6% |
| Max | 9 743.7% |
Other Profitability Ratios
EUCALIA Inc
Glance View
EUCALIA, Inc. engages in the elderly care, hospital management and operations, and medical tourism businesses. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 833 full-time employees. The company went IPO on 2024-12-12. The company operates through three segments. The Medical Management Comprehensive Support Business segment provides comprehensive support for issues faced by affiliated medical corporations, including management consulting, personnel recruitment support, digital transformation (DX) support, and fundraising support. The Senior Related Business segment provides nursing care services such as the operation of nursing care facilities, as well as consultation on admission to nursing care facilities and facility introduction services. The Highly Controlled Medical Device Business segment manufactures and sells contact lenses. The company also provides treatment progress data analysis and sales activity support services for pharmaceutical companies. Through its subsidiaries, it is also engaged in venture investment, as well as the provision of brain checkup services, and real estate buying and selling services.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for EUCALIA Inc is 7.7%, which is below its 3-year median of 9.9%.
Over the last 7 months, EUCALIA Inc’s Operating Margin has decreased from 10.8% to 7.7%. During this period, it reached a low of 7.7% on Oct 30, 2025 and a high of 11.3% on Jun 30, 2025.